Now patients with rheumatoid arthritis (RA) can be diagnosed considerably earlier, thereby increasing their chances of being treated successfully. This is a consequence of new findings by Professor Solbritt Rantapää-Dahlqvist’s research team at the Unit for Rheumology, Department of Public Health and Clinical Medicine, Umeå University in Sweden.
Rheumatoid arthritis, also known as arthritic rheumatism, is a severe disease where the body’s immune defense system attacks the body’s own joint cartilage. In many cases the disease leads to severe pain and crippled joints, above all in the hands and fingers. Hereditary factors have been shown to be important in how the disease develops.
The discovery that patients with rheumatoid arthritis develop antibodies against citrullin (CCP) several years before the onset of the disease represents a new way to diagnose the disorder long before it breaks out. This means that treatment can be introduced even before the patient experiences any symptoms, by so-called screening of middle-aged people with RA in the family.
Bertil Born | alfa
World first: Massive thrombosis removed during early pregnancy
20.07.2017 | Universitätsspital Bern
Therapy of preterm birth in sight?
19.07.2017 | Universitätsspital Bern
21.07.2017 | Event News
19.07.2017 | Event News
12.07.2017 | Event News
21.07.2017 | Earth Sciences
21.07.2017 | Power and Electrical Engineering
21.07.2017 | Physics and Astronomy